| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |